Join
Live feed
·
INSIDERFilingvia Quantisnow
Avalo Therapeutics Inc. logo

Chief Executive Officer Neil Garry Arthur was granted 100,200 shares, increasing direct ownership by 111% to 190,314 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AVTX (Avalo Therapeutics Inc.) and more on Quantisnow.